Search

Your search keyword '"Schwartz, Peter E."' showing total 1,268 results
Start Over Author "Schwartz, Peter E."
1,268 results on '"Schwartz, Peter E."'

1. Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody–drug conjugate, demonstrates in vitro and in vivo antitumor activity against primary and metastatic ovarian tumors overexpressing HER2

Author

Mutlu, Levent, McNamara, Blair, Bellone, Stefania, Manavella, Diego D., Demirkiran, Cem, Greenman, Michelle, Verzosa, Miguel Skyler Z., Buza, Natalia, Hui, Pei, Hartwich, Tobias Max Philipp, Harold, Justin, Yang-Hartwich, Yang, Zipponi, Margherita, Altwerger, Gary, Ratner, Elena, Huang, Gloria S., Clark, Mitchell, Andikyan, Vaagn, Azodi, Masoud, Schwartz, Peter E., and Santin, Alessandro D.

Published
2024
Full Text
View/download PDF

7. Correction: Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer

Author

Roque, Dana M., Siegel, Eric R., Buza, Natalia, Bellone, Stefania, Silasi, Dan-Arin, Huang, Gloria S., Andikyan, Vaagn, Clark, Mitchell, Azodi, Masoud, Schwartz, Peter E., Rao, Gautam G., Reader, Jocelyn C., Hui, Pei, Tymon-Rosario, Joan R., Harold, Justin, Mauricio, Dennis, Zeybek, Burak, Menderes, Gulden, Altwerger, Gary, Ratner, Elena, and Santin, Alessandro D.

Published
2024
Full Text
View/download PDF

10. Stage III uterine serous carcinoma: modern trends in multimodality treatment

Author

Li, Jessie Y, Young, Melissa R, Huang, Gloria, Litkouhi, Babak, Santin, Alessandro, Schwartz, Peter E, and Damast, Shari

Subjects
Reproductive Medicine, Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Clinical Research, Cancer, Adult, Aged, Aged, 80 and over, Brachytherapy, Endometrial Neoplasms, Female, Humans, Hysterectomy, Middle Aged, Neoplasm Staging, Radiotherapy, Adjuvant, Retrospective Studies, Endometrium, Carcinoma, Radiotherapy, Paediatrics and Reproductive Medicine, Oncology and carcinogenesis, Reproductive medicine
Abstract

ObjectiveTo examine outcomes in a modern treatment era for stage III uterine serous carcinoma (USC).MethodsFifty women were retrospectively identified as 2009 International Federation of Gynecology and Obstetrics stage III USC patients who received radiotherapy (RT) at our institution between 1/2003-5/2018. The patients were divided into 2 cohorts: 20 in the early era (2003-2010) and 30 in the modern era (2011-2018). Patient characteristics were compared using χ² tests for categorical variables and t-tests for continuous variables. Recurrence free survival (RFS) and overall survival (OS) were analyzed with Kaplan-Meier estimates, the log-rank test, and Cox proportional hazards.ResultsThe modern era differed from the early era in the increased use of volume-directed external beam RT (EBRT) as opposed to vaginal brachytherapy (VB) alone (33.3% vs 5.0%, p=0.048), minimally invasive surgery (56.7% vs. 25%, p=0.027), sentinel node sampling (26.7% vs. 0%, p=0.012), computed tomography imaging in the perioperative period (63.3% vs. 30%, p=0.044), and human epidermal growth factor receptor 2/neu testing (96.7% vs. 55%, p=0.001). Median follow-up for early and modern eras was 37.27 and 33.23 months, respectively. The early vs. modern 3-year RFS was 33% and 64% (p=0.039), respectively, while the 3-year OS was 55% and 90% (p=0.034). Regional nodal recurrence more common among the patients who received VB only (p=0.048).ConclusionModern era treatment was associated with improved RFS and OS in patients with stage III USC. Regional nodal recurrences were significantly reduced in patients who received EBRT.

Published
2020

11. Uterine leiomyosarcomas harboring MAP2K4 gene amplification are sensitive in vivo to PLX8725, a novel MAP2K4 inhibitor

Author

McNamara, Blair, Harold, Justin, Manavella, Diego, Bellone, Stefania, Mutlu, Levent, Hartwich, Tobias Max Philipp, Zipponi, Margherita, Yang-Hartwich, Yang, Demirkiran, Cem, Verzosa, Miguel Skyler Z., Yang, Kevin, Choi, Jungmin, Dong, Weilai, Buza, Natalia, Hui, Pei, Altwerger, Gary, Huang, Gloria S., Andikyan, Vaagn, Clark, Mitchell, Ratner, Elena, Azodi, Masoud, Schwartz, Peter E., Burton, Elizabeth A., Inagaki, Hiroaki, Albers, Aaron, Zhang, Chao, Bollag, Gideon, Schlessinger, Joseph, and Santin, Alessandro D.

Published
2023
Full Text
View/download PDF

12. The Poly (ADP-ribose) polymerase inhibitor olaparib and pan-ErbB inhibitor neratinib are highly synergistic in HER2 overexpressing epithelial ovarian carcinoma in vitro and in vivo

Author

Han, Chanhee, McNamara, Blair, Bellone, Stefania, Harold, Justin, Manara, Paola, Hartwich, Tobias Max Philipp, Mutlu, Levent, Yang-Hartwich, Yang, Zipponi, Margherita, Demirkiran, Cem, Verzosa, Miguel Skyler Z., Altwerger, Gary, Ratner, Elena, Huang, Gloria S., Clark, Mitchell, Andikyan, Vaagn, Azodi, Masoud, Dottino, Peter R., Schwartz, Peter E., and Santin, Alessandro D.

Published
2023
Full Text
View/download PDF

13. Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody–drug conjugate with topoisomerase I inhibitor payload, shows antitumor activity in uterine and ovarian carcinosarcoma with HER2/neu expression

Author

Mauricio, Dennis, Bellone, Stefania, Mutlu, Levent, McNamara, Blair, Manavella, Diego D., Demirkiran, Cem, Verzosa, Miguel Skyler Z., Buza, Natalia, Hui, Pei, Hartwich, Tobias Max Philipp, Harold, Justin, Yang-Hartwich, Yang, Zipponi, Margherita, Altwerger, Gary, Ratner, Elena, Huang, Gloria S., Clark, Mitchell, Andikyan, Vaagn, Azodi, Masoud, Schwartz, Peter E., and Santin, Alessandro D.

Published
2023
Full Text
View/download PDF

14. Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (ATR) kinase inhibitor

Author

Manavella, Diego D., McNamara, Blair, Harold, Justin, Bellone, Stefania, Hartwich, Tobias Max Philipp, Yang-Hartwich, Yang, Mutlu, Levent, Zipponi, Margherita, Demirkiran, Cem, Verzosa, Miguel Skyler, Altwerger, Gary, Ratner, Elena, Huang, Gloria S., Clark, Mitchell, Andikyan, Vaagn, Azodi, Masoud, Schwartz, Peter E., Dottino, Peter R., Choi, Jungmin, Alexandrov, Ludmil B., Buza, Natalia, Hui, Pei, and Santin, Alessandro D.

Published
2023
Full Text
View/download PDF

15. Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma

Author

Harold, Justin, Bellone, Stefania, Manavella, Diego D., Mutlu, Levent, McNamara, Blair, Hartwich, Tobias Max Philipp, Zipponi, Margherita, Yang-Hartwich, Yang, Demirkiran, Cem, Verzosa, Miguel Skyler, Choi, Jungmin, Dong, Weilai, Buza, Natalia, Hui, Pei, Altwerger, Gary, Huang, Gloria S., Andikyan, Vaagn, Clark, Mitchell, Ratner, Elena, Azodi, Masoud, Schwartz, Peter E., and Santin, Alessandro D.

Published
2023
Full Text
View/download PDF

16. Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer

Author

Roque, Dana M., Siegel, Eric R., Buza, Natalia, Bellone, Stefania, Silasi, Dan-Arin, Huang, Gloria S., Andikyan, Vaagn, Clark, Mitchell, Azodi, Masoud, Schwartz, Peter E., Rao, Gautam G., Reader, Jocelyn C., Hui, Pei, Tymon-Rosario, Joan R., Harold, Justin, Mauricio, Dennis, Zeybek, Burak, Menderes, Gulden, Altwerger, Gary, Ratner, Elena, and Santin, Alessandro D.

Published
2022
Full Text
View/download PDF

17. Synergistic activity of neratinib in combination with olaparib in uterine serous carcinoma overexpressing HER2/neu

Author

Yadav, Ghanshyam, Roque, Dana M., Bellone, Stefania, Manavella, Diego D., Hartwich, Tobias M.P., Zipponi, Margherita, Harold, Justin, Tymon-Rosario, Joan, Mutlu, Levent, Altwerger, Gary, Menderes, Gulden, Ratner, Elena, Buza, Natalia, Hui, Pei, Huang, Gloria S., Andikyan, Vaagn, Clark, Mitchell, Azodi, Masoud, Schwartz, Peter E., Alexandrov, Ludmil B., and Santin, Alessandro D.

Published
2022
Full Text
View/download PDF

18. Homologous recombination deficiency (HRD) signature-3 in ovarian and uterine carcinosarcomas correlates with preclinical sensitivity to Olaparib, a poly (adenosine diphosphate [ADP]- ribose) polymerase (PARP) inhibitor

Author

Tymon-Rosario, Joan R., Manara, Paola, Manavella, Diego D., Bellone, Stefania, Hartwich, Tobias Max Philipp, Harold, Justin, Yang-Hartwich, Yang, Zipponi, Margherita, Choi, Jungmin, Jeong, Kyungjo, Mutlu, Levent, Yang, Kevin, Altwerger, Gary, Menderes, Gulden, Ratner, Elena, Huang, Gloria S., Clark, Mitchell, Andikyan, Vaagn, Azodi, Masoud, Schwartz, Peter E., Alexandrov, Ludmil B., and Santin, Alessandro D.

Published
2022
Full Text
View/download PDF

20. Integrated mutational landscape analysis of uterine leiomyosarcomas

Author

Choi, Jungmin, Manzano, Aranzazu, Dong, Weilai, Bellone, Stefania, Bonazzoli, Elena, Zammataro, Luca, Yao, Xiaotong, Deshpande, Aditya, Zaidi, Samir, Guglielmi, Adele, Gnutti, Barbara, Nagarkatti, Nupur, Tymon-Rosario, Joan R., Harold, Justin, Mauricio, Dennis, Zeybek, Burak, Menderes, Gulden, Altwerger, Gary, Jeong, Kyungjo, Zhao, Siming, Buza, Natalia, Hui, Pei, Ravaggi, Antonella, Bignotti, Eliana, Romani, Chiara, Todeschini, Paola, Zanotti, Laura, Odicino, Franco, Pecorelli, Sergio, Ardighieri, Laura, Bilguvar, Kaya, Quick, Charles M., Silasi, Dan-Arin, Huang, Gloria S., Andikyan, Vaagn, Clark, Mitchell, Ratner, Elena, Azodi, Masoud, Imielinski, Marcin, Schwartz, Peter E., Alexandrov, Ludmil B., Lifton, Richard P., Schlessinger, Joseph, and Santin, Alessandro D.

Published
2021

23. DHES0815A, a novel antibody-drug conjugate targeting HER2/neu, is highly active against uterine serous carcinomas in vitro and in vivo

Author

Tymon-Rosario, Joan, Bonazzoli, Elena, Bellone, Stefania, Manzano, Aranzazu, Pelligra, Silvia, Guglielmi, Adele, Gnutti, Barbara, Nagarkatti, Nupur, Zeybek, Burak, Manara, Paola, Zammataro, Luca, Harold, Justin, Mauricio, Dennis, Buza, Natalia, Hui, Pei, Altwerger, Gary, Menderes, Gulden, Ratner, Elena, Clark, Mitchell, Andikyan, Vaagn, Huang, Gloria S., Silasi, Dan-Arin, Azodi, Masoud, Schwartz, Peter E., and Santin, Alessandro D.

Published
2021
Full Text
View/download PDF

25. Randomized trial of exercise on depressive symptomatology and brain derived neurotrophic factor (BDNF) in ovarian cancer survivors: The Women's Activity and Lifestyle Study in Connecticut (WALC)

Author

Cartmel, Brenda, Hughes, Meghan, Ercolano, Elizabeth A., Gottlieb, Linda, Li, Fangyong, Zhou, Yang, Harrigan, Maura, Ligibel, Jennifer A., von Gruenigen, Vivian E., Gogoi, Radhika, Schwartz, Peter E., Risch, Harvey A., Lu, Lingeng, and Irwin, Melinda L.

Published
2021
Full Text
View/download PDF

26. Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma

Author

Bonazzoli, Elena, Bellone, Stefania, Zammataro, Luca, Gnutti, Barbara, Guglielmi, Adele, Pelligra, Silvia, Nagarkatti, Nupur, Manara, Paola, Tymon-Rosario, Joan, Zeybek, Burak, Altwerger, Gary, Menderes, Gulden, Han, Chanhee, Ratner, Elena, Silasi, Dan-Arin, Huang, Gloria S., Andikyan, Vaagn, Azodi, Masoud, Schwartz, Peter E., and Santin, Alessandro D.

Published
2020
Full Text
View/download PDF

27. Randomized phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum- resistant or refractory ovarian / fallopian tube / primary peritoneal cancer (NCT03093155): updated survival and subgroup analyses

Author

Roque, Dana M., primary, Siegel, Eric R., additional, Buza, Natalia, additional, Bellone, Stefania, additional, Huang, Gloria S., additional, Altwerger, Gary, additional, Andikyan, Vaagn, additional, Clark, Mitchell, additional, Azodi, Masoud, additional, Schwartz, Peter E., additional, Rao, Gautam G., additional, Ratner, Elena, additional, and Santin, Alessandro D., additional

Published
2024
Full Text
View/download PDF

28. Supplementary Data S1 from Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147)

Author

Sheth, Sangini S., primary, Oh, Ji Eun, primary, Bellone, Stefania, primary, Siegel, Eric R., primary, Greenman, Michelle, primary, Mutlu, Levent, primary, McNamara, Blair, primary, Pathy, Shefali, primary, Clark, Mitchell, primary, Azodi, Masoud, primary, Altwerger, Gary, primary, Andikyan, Vaagn, primary, Huang, Gloria, primary, Ratner, Elena, primary, Kim, Daniel J., primary, Iwasaki, Akiko, primary, Levi, Angelique W., primary, Buza, Natalia, primary, Hui, Pei, primary, Flaherty, Sean, primary, Schwartz, Peter E., primary, and Santin, Alessandro D., primary

Published
2024
Full Text
View/download PDF

29. Supplementary Table S1 from Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147)

Author

Sheth, Sangini S., primary, Oh, Ji Eun, primary, Bellone, Stefania, primary, Siegel, Eric R., primary, Greenman, Michelle, primary, Mutlu, Levent, primary, McNamara, Blair, primary, Pathy, Shefali, primary, Clark, Mitchell, primary, Azodi, Masoud, primary, Altwerger, Gary, primary, Andikyan, Vaagn, primary, Huang, Gloria, primary, Ratner, Elena, primary, Kim, Daniel J., primary, Iwasaki, Akiko, primary, Levi, Angelique W., primary, Buza, Natalia, primary, Hui, Pei, primary, Flaherty, Sean, primary, Schwartz, Peter E., primary, and Santin, Alessandro D., primary

Published
2024
Full Text
View/download PDF

30. Supplementary Figure S1 from Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147)

Author

Sheth, Sangini S., primary, Oh, Ji Eun, primary, Bellone, Stefania, primary, Siegel, Eric R., primary, Greenman, Michelle, primary, Mutlu, Levent, primary, McNamara, Blair, primary, Pathy, Shefali, primary, Clark, Mitchell, primary, Azodi, Masoud, primary, Altwerger, Gary, primary, Andikyan, Vaagn, primary, Huang, Gloria, primary, Ratner, Elena, primary, Kim, Daniel J., primary, Iwasaki, Akiko, primary, Levi, Angelique W., primary, Buza, Natalia, primary, Hui, Pei, primary, Flaherty, Sean, primary, Schwartz, Peter E., primary, and Santin, Alessandro D., primary

Published
2024
Full Text
View/download PDF

31. Data from Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147)

Author

Sheth, Sangini S., primary, Oh, Ji Eun, primary, Bellone, Stefania, primary, Siegel, Eric R., primary, Greenman, Michelle, primary, Mutlu, Levent, primary, McNamara, Blair, primary, Pathy, Shefali, primary, Clark, Mitchell, primary, Azodi, Masoud, primary, Altwerger, Gary, primary, Andikyan, Vaagn, primary, Huang, Gloria, primary, Ratner, Elena, primary, Kim, Daniel J., primary, Iwasaki, Akiko, primary, Levi, Angelique W., primary, Buza, Natalia, primary, Hui, Pei, primary, Flaherty, Sean, primary, Schwartz, Peter E., primary, and Santin, Alessandro D., primary

Published
2024
Full Text
View/download PDF

32. Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix

Author

Bellone, Stefania, primary, Jeong, Kyungjo, additional, Halle, Mari Kyllesø, additional, Krakstad, Camilla, additional, McNamara, Blair, additional, Greenman, Michelle, additional, Mutlu, Levent, additional, Demirkiran, Cem, additional, Hartwich, Tobias Max Philipp, additional, Yang-Hartwich, Yang, additional, Zipponi, Margherita, additional, Buza, Natalia, additional, Hui, Pei, additional, Raspagliesi, Francesco, additional, Lopez, Salvatore, additional, Paolini, Biagio, additional, Milione, Massimo, additional, Perrone, Emanuele, additional, Scambia, Giovanni, additional, Altwerger, Gary, additional, Ravaggi, Antonella, additional, Bignotti, Eliana, additional, Huang, Gloria S., additional, Andikyan, Vaagn, additional, Clark, Mitchell, additional, Ratner, Elena, additional, Azodi, Masoud, additional, Schwartz, Peter E., additional, Quick, Charles M., additional, Angioli, Roberto, additional, Terranova, Corrado, additional, Zaidi, Samir, additional, Nandi, Shuvro, additional, Alexandrov, Ludmil B., additional, Siegel, Eric R., additional, Choi, Jungmin, additional, Schlessinger, Joseph, additional, and Santin, Alessandro D., additional

Published
2024
Full Text
View/download PDF

33. Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147)

Author

Sheth, Sangini S., primary, Oh, Ji Eun, additional, Bellone, Stefania, additional, Siegel, Eric R., additional, Greenman, Michelle, additional, Mutlu, Levent, additional, McNamara, Blair, additional, Pathy, Shefali, additional, Clark, Mitchell, additional, Azodi, Masoud, additional, Altwerger, Gary, additional, Andikyan, Vaagn, additional, Huang, Gloria, additional, Ratner, Elena, additional, Kim, Daniel J., additional, Iwasaki, Akiko, additional, Levi, Angelique W., additional, Buza, Natalia, additional, Hui, Pei, additional, Flaherty, Sean, additional, Schwartz, Peter E., additional, and Santin, Alessandro D., additional

Published
2024
Full Text
View/download PDF

34. Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy

Author

Zammataro, Luca, Lopez, Salvatore, Bellone, Stefania, Pettinella, Francesca, Bonazzoli, Elena, Perrone, Emanuele, Zhao, Siming, Menderes, Gulden, Altwerger, Gary, Han, Chanhee, Zeybek, Burak, Bianchi, Anna, Manzano, Aranzazu, Manara, Paola, Cocco, Emiliano, Buza, Natalia, Hui, Pei, Wong, Serena, Ravaggi, Antonella, Bignotti, Eliana, Romani, Chiara, Todeschini, Paola, Zanotti, Laura, Odicino, Franco, Pecorelli, Sergio, Donzelli, Carla, Ardighieri, Laura, Angioli, Roberto, Raspagliesi, Francesco, Scambia, Giovanni, Choi, Jungmin, Dong, Weilai, Bilguvar, Kaya, Alexandrov, Ludmil B., Silasi, Dan-Arin, Huang, Gloria S., Ratner, Elena, Azodi, Masoud, Schwartz, Peter E., Pirazzoli, Valentina, Stiegler, Amy L., Boggon, Titus J., Lifton, Richard P., Schlessinger, Joseph, and Santin, Alessandro D.

Published
2019

35. In vitro and in vivo activity of sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (Trop-2) in uterine serous carcinoma

Author

Han, Chanhee, Perrone, Emanuele, Zeybek, Burak, Bellone, Stefania, Tymon-Rosario, Joan, Altwerger, Gary, Menderes, Gulden, Feinberg, Jacqueline, Haines, Kaitlin, Muller Karger, Mariana Espinal, Bianchi, Anna, Zammataro, Luca, Manzano, Aranzazu, Bonazzoli, Elena, Manara, Paola, Buza, Natalia, Hui, Pei, Ratner, Elena, Silasi, Dan-Arin, Huang, Gloria S., Azodi, Masoud, Schwartz, Peter E., Lopez, Salvatore, and Santin, Alessandro D.

Published
2020
Full Text
View/download PDF

37. PARP-1 activity (PAR) determines the sensitivity of cervical cancer to olaparib

Author

Bianchi, Anna, Lopez, Salvatore, Altwerger, Gary, Bellone, Stefania, Bonazzoli, Elena, Zammataro, Luca, Manzano, Aranzazu, Manara, Paola, Perrone, Emanuele, Zeybek, Burak, Han, Chanhee, Menderes, Gulden, Ratner, Elena, Silasi, Dan-Arin, Huang, Gloria S., Azodi, Masoud, Newberg, Justin Y., Pavlick, Dean C., Elvin, Julia, Frampton, Garrett M., Schwartz, Peter E., and Santin, Alessandro D.

Published
2019
Full Text
View/download PDF

38. PI3K oncogenic mutations mediate resistance to afatinib in HER2/neu overexpressing gynecological cancers

Author

Bonazzoli, Elena, Cocco, Emiliano, Lopez, Salvatore, Bellone, Stefania, Zammataro, Luca, Bianchi, Anna, Manzano, Aranzazu, Yadav, Ghanshyam, Manara, Paola, Perrone, Emanuele, Haines, Kaitlin, Espinal, Mariana, Dugan, Katherine, Menderes, Gulden, Altwerger, Gary, Han, Chanhee, Zeybek, Burak, Litkouhi, Babak, Ratner, Elena, Silasi, Dan-Arin, Huang, Gloria S., Azodi, Masoud, Schwartz, Peter E., and Santin, Alessandro D.

Published
2019
Full Text
View/download PDF

39. Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitor

Author

Li, Charles, Bonazzoli, Elena, Bellone, Stefania, Choi, Jungmin, Dong, Weilai, Menderes, Gulden, Altwerger, Gary, Han, Chanhee, Manzano, Aranzazu, Bianchi, Anna, Pettinella, Francesca, Manara, Paola, Lopez, Salvatore, Yadav, Ghanshyam, Riccio, Francesco, Zammataro, Luca, Zeybek, Burak, Yang-Hartwich, Yang, Buza, Natalia, Hui, Pei, Wong, Serena, Ravaggi, Antonella, Bignotti, Eliana, Romani, Chiara, Todeschini, Paola, Zanotti, Laura, Zizioli, Valentina, Odicino, Franco, Pecorelli, Sergio, Ardighieri, Laura, Silasi, Dan-Arin, Litkouhi, Babak, Ratner, Elena, Azodi, Masoud, Huang, Gloria S., Schwartz, Peter E., Lifton, Richard P., Schlessinger, Joseph, and Santin, Alessandro D.

Published
2019

40. A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma

Author

Han, Chanhee, Bellone, Stefania, Siegel, Eric R., Altwerger, Gary, Menderes, Gulden, Bonazzoli, Elena, Egawa-Takata, Tomomi, Pettinella, Francesca, Bianchi, Anna, Riccio, Francesco, Zammataro, Luca, Yadav, Ghanshyam, Marto, Jarrod A., Penet, Marie-France, Levine, Douglas A., Drapkin, Ronny, Patel, Abhijit, Litkouhi, Babak, Ratner, Elena, Silasi, Dan-Arin, Huang, Gloria S., Azodi, Masoud, Schwartz, Peter E., and Santin, Alessandro D.

Published
2018
Full Text
View/download PDF

42. Tubal Sterilization Rates by State Abortion Laws After the Dobbs Decision.

Author

Xu, Xiao, Chen, Ling, Desai, Vrunda B., Gross, Cary P., Pollack, Craig Evan, Schwartz, Peter E., and Wright, Jason D.

Subjects
TUBAL sterilization, ABORTION laws
Abstract

This study examines whether the use of sterilization procedures changed after the Dobbs ruling by restrictiveness of state abortion laws. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

44. Superior in vitro and in vivo activity of trastuzumab-emtansine (T-DM1) in comparison to trastuzumab, pertuzumab and their combination in epithelial ovarian carcinoma with high HER2/neu expression

Author

Menderes, Gulden, Bonazzoli, Elena, Bellone, Stefania, Altwerger, Gary, Black, Jonathan D., Dugan, Katherine, Pettinella, Francesca, Masserdotti, Alice, Riccio, Francesco, Bianchi, Anna, Zammataro, Luca, de Haydu, Christopher, Buza, Natalia, Hui, Pei, Wong, Serena, Huang, Gloria S., Litkouhi, Babak, Ratner, Elena, Silasi, Dan-Arin, Azodi, Masoud, Schwartz, Peter E., and Santin, Alessandro D.

Published
2017
Full Text
View/download PDF

45. SYD985, a novel duocarmycin-based HER2-targeting antibody-drug conjugate, shows promising antitumor activity in epithelial ovarian carcinoma with HER2/Neu expression

Author

Menderes, Gulden, Bonazzoli, Elena, Bellone, Stefania, Black, Jonathan, Altwerger, Gary, Masserdotti, Alice, Pettinella, Francesca, Zammataro, Luca, Buza, Natalia, Hui, Pei, Wong, Serena, Litkouhi, Babak, Ratner, Elena, Silasi, Dan-Arin, Huang, Gloria S., Azodi, Masoud, Schwartz, Peter E., and Santin, Alessandro D.

Published
2017
Full Text
View/download PDF

48. Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro

Author

Bellone, Stefania, Bignotti, Eliana, Lonardi, Silvia, Ferrari, Francesca, Centritto, Floriana, Masserdotti, Alice, Pettinella, Francesca, Black, Jonathan, Menderes, Gulden, Altwerger, Gary, Hui, Pei, Lopez, Salvatore, de Haydu, Christopher, Bonazzoli, Elena, Predolini, Federica, Zammataro, Luca, Cocco, Emiliano, Ferrari, Federico, Ravaggi, Antonella, Romani, Chiara, Facchetti, Fabio, Sartori, Enrico, Odicino, Franco E., Silasi, Dan-Arin, Litkouhi, Babak, Ratner, Elena, Azodi, Masoud, Schwartz, Peter E., and Santin, Alessandro D.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results